Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00687999
Show Display Options
Rank Status Study
1 Completed NIDDM and IR in Combination Therapy for CHC
Conditions: Chronic Hepatitis C;   Insulin Resistance
Intervention: Drug: pegylated interferon alpha and ribavirin

Indicates status has not been verified in more than two years